期刊文献+

Combined thrombectomy and intracoronary administration of glycoprotein IIb/IIIa inhibitors improves myocardial reperfusion in patients undergoing primary percutaneous coronary intervention: a meta-analysis 被引量:3

Combined thrombectomy and intracoronary administration of glycoprotein IIb/IIIa inhibitors improves myocardial reperfusion in patients undergoing primary percutaneous coronary intervention: a meta-analysis
下载PDF
导出
摘要 BackgroundSuboptimal 心肌的灌注在有圣片断举起的病人是普通的经历主要经皮的冠的干预(PPCI ) 的心肌的梗塞(STEMI ) 。而且,它导致增加的梗塞尺寸和死亡率。我们执行了元分析评估渴望 thrombectomy 的角色(在)在心肌的灌注和临床的 outcomes.MethodsPubMed 的改进与 glycoprotein IIb/IIIa 禁止者( GPI )的 intracoronary 管理结合了, Embase ,科学的网,并且中央数据库被寻找因为调查的使随机化的控制试用( RCT )联合了在并且 intracoronary GPI 治疗对在独自一个。利息的结果是在心肌的梗塞的 thrombolysis 心肌的灌注等级( TMPG ),梗塞尺寸()由心脏的磁性的回声成像估计了,左室的喷射部分( LVEF ),主要不利心脏的事件(向)在短期( 1 个月)并且长期( 6-12 月)后续,并且在包含 923 个病人的医院 stay.ResultsEight 试用期间为复杂并发症放血被包括。与相比在独自一个,联合了在, intracoronary GPI 显著地增加了 TMPG 3 流动(RR:1.15, 95% CI:1.04 ~ 1.26 ) ,减少[吝啬的差别(MD ) :-3.46,95% CI:-5.18 到 -1.73], 和改进 LVEF (MD:1.44, 95% CI:0.54 ~ 2.33 ) 。而且, GPI 使用减少了在长期的后续的向的风险(RR:0.60, 95% CI:0.37 ~ 0.98 ) 。在未成年者的发生的二个组之间没有重要差别,主要流血 complications.ConclusionsOur 调查结果显示出那与相比在独自一个,联合了在, intracoronary GPI 治疗导致了改进心肌的灌注,更好心脏的功能,并且没有向的幸存与经历 PPCI 的 STEMI 为病人在长期的后续受益。 Background Suboptimal myocardial reperfusion is common in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). Furthermore, it results in increased infarct size and mortality rates. We performed a meta-analysis to evaluate the role of aspiration thrombectomy (AT) combined with intracoronary administration of glycoprotein IIb/IIIa inhibitors (GPI) in the improvement of myocardial reperfusion and clinical outcomes. Methods PubMed, Embase, Web of Science, and CENTRAL databases were searched for randomized controlled trials (RCTs) investigating combined AT and intracoronary GPI treatment versus AT alone. Outcomes of interest were thrombolysis in myocardial infarction myocardial perfusion grade (TMPG), infarct size (IS) assessed by cardiac magnetic resonance imaging, left ventricular ejection fraction (LVEF), major adverse cardiac events (MACE) at short-term (〈 1 month) and long-term (6-12 months) follow-up, and bleeding complications during the hospital stay. Results Eight trials involving 923 patients were included. Compared with AT alone, combined AT and intracoronary GPI significantly increased TMPG 3 flow (RR: 1.15, 95% CI: 1.04 to 1.26), reduced IS [mean difference (MD): -3.46, 95% CI: -5.18 to -1.73], and improved LVEF (MD: 1.44, 95% CI: 0.54 to 2.33). Furthermore, GPI use decreased the risk of MACE at long-term follow-up (RR: 0.60, 95% CI: 0.37 to 0.98). There was no significant difference between the two groups in the incidence of minor and major bleeding complications. Conclusions Our findings showed that compared with AT alone, combined AT and intracoronary GPI treatment resulted in improved myocardial reperfusion, better cardiac function, and MACE-free survival benefits at the long-term follow-up for patients with STEMI undergoing PPCI.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2017年第10期614-623,共10页 老年心脏病学杂志(英文版)
关键词 Glycoprotein IIb/IIIa 禁止者 元分析 心肌的灌注 THROMBECTOMY 经皮的冠的干预 Glycoprotein llb/IIIa inhibitors Meta-analysis Myocardial reperfusion Thrombectomy Percutaneous coronary intervention
  • 相关文献

参考文献4

二级参考文献56

  • 1杨新春,张大鹏,王乐丰,徐立,葛永贵,王红石,李惟铭,倪祝华,夏昆,连勇,薛永利,马利祥.冠状动脉内应用国产替罗非班对急性ST段抬高心肌梗死急诊介入治疗后心肌灌注和临床预后的影响[J].中华心血管病杂志,2007,35(6):517-522. 被引量:73
  • 2Ito H, Okamura A, Iwakura K, et al.Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction[J].Circulation, 1996, 93: 1993-1999.
  • 3Tanaka A, Kawarabayashi T, Nishibori Y, et al.No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction[J].Circulation, 2002, 105: 2148- 2152.
  • 4Yip HK, Chen MC, Chang HW, et al.Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon[J].Chest, 2002, 122:1322-1332.
  • 5Hara M, Saikawa T, Tsunematsu Y, et al.Predicting no-reflow based on angiographic features of lesions in patients with acute myocardial infarction[J].J Atheroscler Thromb, 2005, 12:315-321.
  • 6Chesebro JH, Knatterud G, Roberts R, et al.Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase.Clinical findings through hospital discharge[J].Circulation, 1987, 76:142-154.
  • 7Gibson CM, Cannon CP, Murphy SA, et al.Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs[J].Circulation, 2000, 101:125-130.
  • 8O′Gara PT, Kushner FG, Ascheim DD,et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol, 2013,61:e78-e140.
  • 9Hillegass WB, Dean NA, Liao L, et al.Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience[J].J Am Coll Cardiol, 2001, 37: 1335-1343.
  • 10Niccoli G, D′amario D, Spaziani C, et al.Randomized evaluation of intracoronary nitroprusside vs.adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol[J].J Cardiovasc Med (Hagerstown), 2009,10:585-592.

共引文献128

同被引文献17

引证文献3

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部